| Previous Close | 4.15 |
| Open | 4.15 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 4.00 - 4.55 |
| 52 Week Range | 0.70 - 12.00 |
| Volume | 8,534 |
| Avg. Volume | 2,940 |
| Market Cap | 4.41M |
| Beta | 2.14 |
| PE Ratio (TTM) | -1.06 |
| EPS (TTM) | -3.77 |
| Earnings Date | Nov 14, 2017 - Nov 20, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.57 |
- Marketwired•yesterday
Pressure BioSciences' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards
Pressure BioSciences, Inc. , a leader in the development and sale of broadly enabling, pressure cycling technology -based sample preparation solutions to the worldwide life sciences industry, today announced ...
- Marketwired•8 days ago
Pressure BioSciences, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on September 11, 2017
Pressure BioSciences, Inc. , a leader in the development and sale of broadly enabling, pressure cycling technology -based sample preparation solutions to the worldwide life sciences industry, today announced ...
Capital Cube•25 days agoPressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
Categories: Yahoo FinanceGet free summary analysis Pressure BioSciences, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Pressure BioSciences, Inc. – Waters Corporation, Bruker Corporation, General Electric Company, Harvard Bioscience, Inc., Thermo Fisher Scientific Inc. and PerkinElmer, Inc. (WAT-US, BRKR-US, GE-US, HBIO-US, TMO-US and PKI-US) ... Read more (Read more...)
